Contract Service Directory

Avior Risk and Compliance Assessment and Management





Company Headquarters

11 Perimeter Rd.
Nashua, NH 03063
United States

Contract Service Directory

    Related Content

    • Pharmaceutical Development for ADCs

      Pharmaceutical Development for ADCs

      Download the ADCs Poster.

    • Enhanced Delivery Options for Injectables

      Enhanced Delivery Options for Injectables

      Download the Enhanced Delivery Options Poster.

    • BIOSIMILARS: Global Terminology, Strategy & Pathways

      BIOSIMILARS: Global Terminology, Strategy & Pathways

      Download the Global Terminology, Strategy & Pathways Poster


    • Promotions & Moves

      Akebia Therapeutics Names CMO

      Jain to lead clinical development of the company’s HIF pipeline
      05.25.17

    • Clean Air and Containment Decision Map

      Clean Air and Containment Decision Map

      A risk assessment for the laboratory space should be prepared by, for example, the institution’s Biological Safety Officer.

    • Regulatory Affairs
      Leveraging Next-Gen FSP Models to Better Manage Post-approval Regulatory Workloads

      Leveraging Next-Gen FSP Models to Better Manage Post-approval Regulatory Workloads

      One-team Model forges an outsourcing partnership to deliver efficient global regulatory lifecycle management
      Elizabeth Madichie, Alistair Davidson, Denise Moody and Vincenzo Cannizzaro, PPD 05.09.17


    • Injectable Drug Delivery Trends

      Graham Reynolds of West discusses the latest drug delivery strategies and trends
      Kristin Brooks, Contract Pharma 04.20.17

    • Analytical Services
      Quality Risk Management

      Quality Risk Management

      It’s not just for the big guys anymore
      Emil W. Ciurczak, DoraMaxx Consulting 04.03.17

    • Elemental Impurities: A Virtual Company Perspective

      Elemental Impurities: A Virtual Company Perspective

      A look at risk assessments for elemental impurity determinations in oral tablet and parenteral drug products.
      Anthony DeStefano and Thomas Kester, Recordati Rare Diseases, Inc. 04.03.17


    • Clinical Trials | CRO News | Drug Development

      ICON, Pfizer Ink Services Pact

      To support Pfizer’s global drug development efforts for three years
      06.10.16


    • Promotions & Moves

      Avion Pharma Names CEO

      Current chief operating officer Harold Deas to assume chief exec role
      04.12.16


    • Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Preclinical Outsourcing

      Hemispherx Enters Agreement With myTomorrows

      Will focus on early access program for rintatolimod in Europe
      08.10.15